Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ARES vs GSK✓SelectedUSD · GSKARES vs GSK performance historyLatest closeAs of-2.78%11/19
Stock and ETF performance explorer

ARES vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.5%
GSK return
+39.6%
Excess return
+25.9%
Maximum drawdown
-50.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-1.6%-1.2%-2.5%
7D-6.7%-4.7%-1.9%-5.9%
30D+7.0%-4.7%+11.7%+7.8%
3M-12.1%-8.8%-3.4%-11.0%
6M+4.9%-4.6%+9.5%+5.5%
YTD-20.4%+1.0%-21.3%-20.9%
1Y-10.7%+6.9%-17.6%-12.1%
3Y+27.6%+52.5%-25.0%+12.8%
5Y+65.5%+40.3%+25.2%+42.0%
All+65.5%+39.6%+25.9%+42.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling